의료진

의료진소개

배영경 사진

배영경

  • [진료과] 병리과
  • [주연구분야] 유전자발현 양상에 따른 유방암의 예후인자
  • [직위] 교수
  • [진료과목] 유방병리, 피부병리

진료예약

병리과 의료진의 진료과목, 오전과 오후의 예약가능 요일을 알려주며 예약관련 링크 제공
의사 진료과목 구분 예약
배영경 유방병리, 피부병리 오전 예약가능 예약가능 예약가능 예약가능 예약가능 전화 예약
(620-4030)
오후 예약가능 예약가능 예약가능 예약가능 예약가능

경력

미국 존스홉킨스병원 병리과 연수 (visiting scholar)
영남대학교 의과대학 전임강사, 조교수, 부교수
영남대학교 의과대학 교수 (2012-현재)

학회 및 대외활동

[학회활동]
대한병리학회, 대한세포병리학회, 한국유방암학회, 대한암학회, 미국캐나다병리학회 정회원
대한병리학회/대한세포병리학회 편집위원
대한병리학회/대한세포병리학회 학술위원
대한세포병리학회 지도의/자격인정위원

[수상경력]
2018 한국유방암학회 우수논문상 (Best paper award)
2012 한국유방암학회 우수논문상 (Best paper award)
2012 영남의대 우수연구교수
2010 한국유방암학회 학술상 (우수연제상)
2009 한국유방암학회 동아학술상 (우수논문상)

[발표논문-주저자]
Park MH, Kwon SY, Choi JE, Gong G, Bae YK. Intratumoral CD103-positive Tumor-Infiltrating Lymphocytes Are Associated With Favorable Prognosis in Patients With Triple-Negative Breast Cancer. Histopathology. 2020 Apr 25. doi: 10.1111/his.14126. Online ahead of print.
Gorbounov M, Carleton NM, Asch-Kendrick RJ, Xian L, Rooper L, Chia L, Cimino-Mathews A, Cope L, Meeker A, Stearns V, Veltri RW, Bae YK*, Resar LMS*. (*co-corresponding) High Mobility Group A1 (HMGA1) Protein and Gene Correlate With ER-negativity and Poor Outcomes in Breast Cancer. Breast Cancer Res Treat. 2020;179(1):25-35.
Kim MC, Park MH, Kang SH, Bae YK. NDRG3 Protein Is Associated With Aggressive Biologic Phenotype and Unfavorable Outcome in Patients With Invasive Breast Cancer. Int J Clin Exp Pathol. 2019;12(10):3886-3893.
Baek J, Jang N, Choi JE, Kim JR, Bae YK. CD9 in Tumor Cells Is Associated with Poor Prognosis in Patients with Invasive Lobular Carcinoma. J Breast Cancer. 2019;22(1):77-85.
Jang N, Choi JE, Kang SH, Bae YK. Validation of the Pathological Prognostic Staging System Proposed in the Revised 8th Edition of the AJCC Staging Manual in Different Molecular Subtypes of Breast Cancer. Virchows Arch. 2019;474(2):193-200.
Kwon HJ, Choi JE, Bae YK. Interleukin-13 receptor alpha 2 in tumor cells is associated with reduced disease-free survival in patients with luminal subtype invasive breast cancer. Tumour Biol. 2018;40(6):1010428318783657.
Jang N, Kwon HJ, Park MH, Kang SH, Bae YK. Prognostic Value of Tumor-Infiltrating Lymphocyte Density Assessed Using a Standardized Method d on Molecular Subtypes and Adjuvant Chemotherapy in Invasive Breast Cancer. Ann Surg Oncol. 2018;25(4):937-946.
Kim A, Jang MH, Lee SJ, Bae YK. Mutations of the Epidermal Growth Factor Receptor Gene in Triple-Negative Breast Cancer. J Breast Cancer. 2017;20(2):150-159.
Park MH, Kwon HJ, Kim JR, Lee B, Lee SJ, Bae YK. Elevated Interleukin-13 Receptor Alpha 1 in Tumor Cells Is Associated with Poor Prognosis in Patients with Invasive Breast Cancer. Ann Surg Oncol. 2017;24(12):3780-3787.
Kwon HJ, Choi JE, Kang SH, Son Y, Bae YK. Prognostic significance of CD9 differs between tumour cells and stromal immune cells, and depends on the molecular subtype of the invasive breast carcinoma. Histopathology. 2017;70(7):1155-1165.
Gautam J, Bae YK, Kim JA. Up-regulation of cathepsin S by HSP90 and 5-HT7 receptor-dependent serotonin signaling correlates with triple negativity of human breast cancer. Breast Cancer Res Treat. 2017;161(1):29-40.
Kim KJ, Kwon HJ, Kim MC, Bae YK. CD9 in Colorectal Carcinomas and Its Prognostic Significance. J Pathol Transl Med. 2016;50(6):459-468.
Kim MC, Choi JE, Lee SJ, Bae YK. Coexistent Loss of the s of BRCA1 and p53 Predicts Poor Prognosis in Triple-Negative Breast Cancer. Ann Surg Oncol. 2016;23(11):3524-3530.
Bae YK, Choi JE, Kang SH, Lee SJ. Epithelial-Mesenchymal Transition Phenotype Is Associated with Clinicopathological Factors That Indicate Aggressive Biological Behavior and Poor Clinical Outcomes in Invasive Breast Cancer. J Breast Cancer. 2015;18(3):256-63.
Choi JE, Kang SH, Lee SJ, Bae YK. Prognostic significance of Bcl-2 in non-basal triple-negative breast cancer patients treated with anthracycline-d chemotherapy. Tumour Biol. 2014;35(12):12255-63.
Choi JE, Kang SH, Lee SJ, Bae YK. Androgen receptor predicts decreased survival in early stage triple-negative breast cancer. Ann Surg Oncol. 2015;22(1):82-9.
Bae YK, Kim A, Kim MK, Choi JE, Kang SH, Lee SJ. Fibronectin in carcinoma cells correlates with tumor aggressiveness and poor clinical outcome in patients with invasive breast cancer. Hum Pathol. 2013;44(10):2028-37.
Kim A, Bae YK, Gu MJ, Kim JY, Jang KY, Bae HI, Lee HJ, Hong SM. Epithelial-mesenchymal transition phenotype is associated with patient survival in small intestinal adenocarcinoma. Pathology. 2013;45(6):567-73.
Bae YK, Gong G, Kang J, Lee A, Cho EY, Lee JS, Suh KS, Lee DW, Jung WH; Breast Pathology Study Group of Korean Society of Pathologists. HER2 Status by Standardized Immunohistochemistry and Silver-Enhanced In Situ Hybridization in Korean Breast Cancer. J Breast Cancer. 2012;15(4):381-7.
Bae YK, Gong G, Kang J, Lee A, Cho EY, Lee JS, Suh KS, Lee DW. Hormone receptor in invasive breast cancer among Korean women and comparison of 3 antiestrogen receptor antibodies: a multi-institutional retrospective study using tissue microarrays. Am J Surg Pathol. 2012;36(12):1817-25.
Kim A, Shin HC, Bae YK, Kim MK, Kang SH, Lee SJ, Lee EH. Multiplication of Chromosome 17 Centromere Is Associated with Prognosis in Patients with Invasive Breast Cancers Exhibiting Normal HER2 and TOP2A Status. J Breast Cancer. 2012;15(1):24-33.

방송출연

질병백과

언론보도